-
Sitagliptin, sold
under the
brand name
Januvia among others, is an anti-diabetic
medication used to
treat type 2 diabetes. In the
United Kingdom it is...
-
Sitagliptin/metformin, sold
under the
brand name
Janumet among others, is a fixed-dose
combination anti-diabetic
medication used to
treat type 2 diabetes...
-
incretins and
various combinations.
Sitagliptin patent expired in July 2022,
leading to
launch of
generic sitagliptin brands . This
lowered the cost of...
- for use as a
monotherapy and as a
fixed dose
combination with
either sitagliptin or with metformin. In the
European Union, it was
approved in
March 2018...
- used to
treat diabetes mellitus type 2. The
first agent of the
class –
sitagliptin – was
approved by the FDA in 2006.
Glucagon increases blood glucose levels...
-
twice daily,
sitagliptin and rosiglitazone. In a
randomized controlled trial (RCT)
comparing liraglutide, glargine, glimepiride, and
sitagliptin (all added...
-
Milicevic Z (August 2014). "Efficacy and
safety of
dulaglutide versus sitagliptin after 52 w****s in type 2
diabetes in a
randomized controlled trial (AWARD-5)"...
-
pioglitazone A10BD06
Glimepiride and
pioglitazone A10BD07
Metformin and
sitagliptin A10BD08
Metformin and
vildagliptin A10BD09
Pioglitazone and alogliptin...
-
Sitagliptin/simvastatin, sold
under the
brand name Juvisync, is a fixed-dose
combination anti-diabetic
medication used to
treat type 2
diabetes and hypercholesterolemia...
- Pioglitazone/
sitagliptin Rosiglitazone/metformin Saxagliptin/metformin
Sitagliptin/dapagliflozin
Sitagliptin/ertugliflozin
Sitagliptin/metformin
Sitagliptin/simvastatin...
